Skip to main content

24 May 2022

Last updated: Tuesday 24 May 2022

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Build-to-buy model attracts Pharma investors

Tuesday 26 August 2014

Interviewee/Contributor

Clare Ozawa

Organisation

Inception Sciences Inc

Organisations

Acesion Pharma ApS
AgomAb Therapeutics NV
CellCentric Ltd
NDA Advisory Services Ltd
Pharming Group NV
Aravis Venture
NDA Group AB
GW Pharmaceuticals Plc
Oryx GmbH & Co KG and Valo Therapeutics Ltd
Cancer Research UK

Interviewees and Contributers

Christian Jørgensen
Andreas Posch, Achim Plum and Richard Zahrl
Olav Hellebø
Steven D. Pearson
Clementine Brooks and Amy Ellington
Katherine Smith
Jürg Eckhardt
Bart Bergstein
Jonathan Moore
Sean Morgan-Jones

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Tim Obara joins Genenta

Friday 13 May 2022

ADC Therapeutics appoints CEO

Friday 13 May 2022

Leopold Bertea joins Immunicum

Friday 13 May 2022

Joanna Brewer becomes CSO at Adaptimmune

Friday 13 May 2022

Bernhard Ehmer joins board of Achilles

Friday 13 May 2022

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2022 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form